Designing better ways to deliver drugs
Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
Graduate student and MathWorks Fellow Louis DeRidder is developing a device to make chemotherapy dosing more accurate for individual patients.
Spheric Bio’s implants are designed to grow in a channel of the heart to better fit the patient’s anatomy and prevent strokes.
Colleagues remember the longtime MIT professor as a supportive, energetic collaborator who seemed to know everyone at the Institute.
For the past decade, the Abdul Latif Jameel Water and Food Systems Lab has strengthened MIT faculty efforts in water and food research and innovation.
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
The nitrogen product developed by the company, which was co-founded by Professor Chris Voigt, is being used across millions of acres of American farmland.
Butlr, founded by former Media Lab researchers, uses insights from thermal sensors to make buildings safe and efficient.
With technology developed at MIT, 6K is helping to bring critical materials production back to the U.S. without toxic byproducts.
Engineer and historian David Mindell’s new book provides a roadmap for thinking about the future of industry.
Doug Field SM ’92, Ford’s chief of EVs and digital design, leads the legacy carmaker into the software-enabled, battery-propelled future.
The consortium will bring researchers and industry together to focus on impact.
The company builds water recycling, treatment, and purification solutions for some of the world’s largest brands.
The course challenges students to commercialize technologies and ideas in one whirlwind semester. Alumni of the class have founded more than 150 companies.
The associate leader in the Advanced Materials and Microsystems Group at Lincoln Laboratory strongly believes in the power of collaboration and how it seeds innovation.
When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.